» Articles » PMID: 37307562

SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities Through a Ternary Complex Mechanism

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2023 Jun 12
PMID 37307562
Authors
Affiliations
Soon will be listed here.
Abstract

Sterile alpha and toll/interleukin receptor (TIR) motif containing protein 1 (SARM1) is an NAD hydrolase and cyclase involved in axonal degeneration. In addition to NAD hydrolysis and cyclization, SARM1 catalyzes a base exchange reaction between nicotinic acid (NA) and NADP to generate NAADP, which is a potent calcium signaling molecule. Herein, we describe efforts to characterize the hydrolysis, cyclization, and base exchange activities of TIR-1, the ortholog of SARM1; TIR-1 also catalyzes NAD(P) hydrolysis and/or cyclization and regulates axonal degeneration in worms. We show that the catalytic domain of TIR-1 undergoes a liquid-to-solid phase transition that regulates not only the hydrolysis and cyclization reactions but also the base exchange reaction. We define the substrate specificities of the reactions, demonstrate that cyclization and base exchange reactions occur within the same pH range, and establish that TIR-1 uses a ternary complex mechanism. Overall, our findings will aid drug discovery efforts and provide insight into the mechanism of recently described inhibitors.

Citing Articles

Subcellular NAD pools are interconnected and buffered by mitochondrial NAD.

Hoyland L, VanLinden M, Niere M, Stromland O, Sharma S, Dietze J Nat Metab. 2024; 6(12):2319-2337.

PMID: 39702414 DOI: 10.1038/s42255-024-01174-w.


Adaptation of a Commercial NAD Quantification Kit to Assay the Base-Exchange Activity and Substrate Preferences of SARM1.

Cirilli I, Amici A, Gilley J, Coleman M, Orsomando G Molecules. 2024; 29(4).

PMID: 38398599 PMC: 10891823. DOI: 10.3390/molecules29040847.

References
1.
Essuman K, Summers D, Sasaki Y, Mao X, DiAntonio A, Milbrandt J . The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD Cleavage Activity that Promotes Pathological Axonal Degeneration. Neuron. 2017; 93(6):1334-1343.e5. PMC: 6284238. DOI: 10.1016/j.neuron.2017.02.022. View

2.
Hughes R, Bosanac T, Mao X, Engber T, DiAntonio A, Milbrandt J . Small Molecule SARM1 Inhibitors Recapitulate the SARM1 Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate. Cell Rep. 2021; 34(1):108588. PMC: 8179325. DOI: 10.1016/j.celrep.2020.108588. View

3.
Gerdts J, Summers D, Sasaki Y, DiAntonio A, Milbrandt J . Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J Neurosci. 2013; 33(33):13569-80. PMC: 3742939. DOI: 10.1523/JNEUROSCI.1197-13.2013. View

4.
Lee H, Zhao Y . Resolving the topological enigma in Ca signaling by cyclic ADP-ribose and NAADP. J Biol Chem. 2019; 294(52):19831-19843. PMC: 6937575. DOI: 10.1074/jbc.REV119.009635. View

5.
George E, Glass J, Griffin J . Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci. 1995; 15(10):6445-52. PMC: 6577979. View